WINOOSKI VT, USA – BioTek’s Synergy™ Neo2 Multi-Mode Microplate Reader offers even more powerful performance and assay flexibility for screening and core laboratories with an optional TRF laser. Along with dual photomultiplier tube (PMT) detection, the 337 nm laser provides the exceptional processing speed and maximum sensitivity necessary for high-quality time-resolved fluorescence (TRF) and time-resolved fluorescence resonance energy transfer (TR-FRET) results.

Synergy Neo2 provides a wide range of capabilities to facilitate an endless number of high-throughput biochemical and cell-based assay workflows. Patented Hybrid Technology™, with variable bandwidth quad monochromators and sensitive high-transmission filter optics, enables wide flexibility in assay choice. Advanced environmental controls, including incubation to 65 ºC, CO2/O2 regulation, and variable shaking, along with direct bottom detection, support live cell assays. Gen5™ Software controls Synergy Neo2 and enables powerful data analysis. Synergy Neo2 may be linked with BioTek’s BioStack™ Neo or third-party robotic systems for walk-away automation and further enhanced throughput, and may also be easily integrated with any laboratory information management system (LIMS).

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations.